These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27477089)

  • 1. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 3. Apparent discrepancies between LLNA and GPMT sensitisation potential: False positives or differences in sensitivity?
    Roberts DW; Schultz TW; Api AM
    Regul Toxicol Pharmacol; 2016 Oct; 80():260-7. PubMed ID: 27477089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitization potency. Part 1. Underlying physical organic chemistry principles and the extent to which they are represented in the LLNA validation dataset.
    Roberts DW; Api AM; Patlewicz G; Schultz TW
    Regul Toxicol Pharmacol; 2016 Oct; 80():247-54. PubMed ID: 27424000
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the skin sensitizing potential of unsaturated compounds as assessed by the murine local lymph node assay (LLNA) and the guinea pig maximization test (GPMT).
    Kreiling R; Hollnagel HM; Hareng L; Eigler D; Lee MS; Griem P; Dreessen B; Kleber M; Albrecht A; Garcia C; Wendel A
    Food Chem Toxicol; 2008 Jun; 46(6):1896-904. PubMed ID: 18343554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical applicability domain of the local lymph node assay (LLNA) for skin sensitisation potency. Part 4. Quantitative correlation of LLNA potency with human potency.
    Roberts DW; Api AM
    Regul Toxicol Pharmacol; 2018 Jul; 96():76-84. PubMed ID: 29730445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the local lymph node assay (LLNA) for skin sensitisation.
    Roberts DW; Kimber I; Basketter DA
    Regul Toxicol Pharmacol; 2023 Jun; 141():105402. PubMed ID: 37116738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
    Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
    Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsaturated fatty acids show clear elicitation responses in a modified local lymph node assay with an elicitation phase, and test positive in the direct peptide reactivity assay.
    Yamashita K; Shinoda S; Hagiwara S; Miyazaki H; Itagaki H
    J Toxicol Sci; 2015 Dec; 40(6):843-53. PubMed ID: 26558466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
    Haneke KE; Tice RR; Carson BL; Margolin BH; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative comparison of the results obtained by the multiple-dose guinea pig maximization test and the non-radioactive murine local lymph-node assay for various biocides.
    Yamano T; Shimizu M; Noda T
    Toxicology; 2005 Jul; 211(1-2):165-75. PubMed ID: 15863260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dose-responses of contact allergens using the guinea pig maximization test and the local lymph node assay.
    van Och FM; Vandebriel RJ; Prinsen MK; De Jong WH; Slob W; van Loveren H
    Toxicology; 2001 Oct; 167(3):207-15. PubMed ID: 11578800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin irritation, false positives and the local lymph node assay: a guideline issue?
    Basketter DA; Kimber I
    Regul Toxicol Pharmacol; 2011 Oct; 61(1):137-40. PubMed ID: 21803111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.
    Idehara K; Yamagishi G; Yamashita K; Ito M
    J Pharmacol Toxicol Methods; 2008; 58(1):1-10. PubMed ID: 18462956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin sensitization, false positives and false negatives: experience with guinea pig assays.
    Basketter DA; Kimber I
    J Appl Toxicol; 2010 Jul; 30(5):381-6. PubMed ID: 20583317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulatory use of the Local Lymph Node Assay for the notification of new chemicals in Europe.
    Angers-Loustau A; Tosti L; Casati S
    Regul Toxicol Pharmacol; 2011 Aug; 60(3):300-7. PubMed ID: 21539884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement.
    Omori T; Idehara K; Kojima H; Sozu T; Arima K; Goto H; Hanada T; Ikarashi Y; Inoda T; Kanazawa Y; Kosaka T; Maki E; Morimoto T; Shinoda S; Shinoda N; Takeyoshi M; Tanaka M; Uratani M; Usami M; Yamanaka A; Yoneda T; Yoshimura I; Yuasa A
    J Pharmacol Toxicol Methods; 2008; 58(1):11-26. PubMed ID: 18593646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.
    Dean JH; Twerdok LE; Tice RR; Sailstad DM; Hattan DG; Stokes WS
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):258-73. PubMed ID: 11754530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
    Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
    Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.